Circulating MicroRNAs are Biomarkers of Various Diseases

Case ID:
C11164
Disclosure Date:
7/6/2010
Description:
Unmet Need: Esophageal adenocarcinoma (EAC) is one of the most rapidly increasing cancers in the United States and throughout the developed world. The current primary screening method for EAC is gastrointestinal endoscopy; however, this method is unsuitable and impractical for population-based screening or detection of asymptomatic EAC. Developing a test using biomarkers of EAC discovered in blood would be a cheaper, less invasive, and more robust alternative.
JHU scientists have developed an microRNA biomarker assay to diagnose and monitor EAC.
Patent Information:
Inventors:
Category(s):
For Information, Contact:
Nakisha Holder
nickki@jhu.edu
410-614-0300
Save This Technology:
2017 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum